nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Paget's disease of bone—osteoporosis	0.176	1	CtDrD
Zoledronate—FDPS—osteoporosis	0.113	0.784	CbGaD
Zoledronate—Ibandronate—osteoporosis	0.0723	0.268	CrCtD
Zoledronate—FDPS—Ibandronate—osteoporosis	0.0614	0.361	CbGbCtD
Zoledronate—Risedronate—osteoporosis	0.051	0.189	CrCtD
Zoledronate—Etidronic acid—osteoporosis	0.051	0.189	CrCtD
Zoledronate—Pamidronate—osteoporosis	0.0479	0.177	CrCtD
Zoledronate—Alendronate—osteoporosis	0.0479	0.177	CrCtD
Zoledronate—FDPS—Pamidronate—osteoporosis	0.0465	0.274	CbGbCtD
Zoledronate—FDPS—Risedronate—osteoporosis	0.0352	0.207	CbGbCtD
Zoledronate—CA2—osteoporosis	0.0313	0.216	CbGaD
Zoledronate—FDPS—Alendronate—osteoporosis	0.0244	0.144	CbGbCtD
Zoledronate—Risedronate—Ibandronate—osteoporosis	0.0102	0.0573	CrCrCtD
Zoledronate—Etidronic acid—Ibandronate—osteoporosis	0.0102	0.0573	CrCrCtD
Zoledronate—Clodronate—Etidronic acid—osteoporosis	0.00997	0.0558	CrCrCtD
Zoledronate—Clodronate—Alendronate—osteoporosis	0.00937	0.0525	CrCrCtD
Zoledronate—Clodronate—Pamidronate—osteoporosis	0.00937	0.0525	CrCrCtD
Zoledronate—Pamidronate—Ibandronate—osteoporosis	0.00904	0.0506	CrCrCtD
Zoledronate—Alendronate—Ibandronate—osteoporosis	0.00904	0.0506	CrCrCtD
Zoledronate—Ibandronate—Risedronate—osteoporosis	0.00834	0.0467	CrCrCtD
Zoledronate—Ibandronate—Etidronic acid—osteoporosis	0.00834	0.0467	CrCrCtD
Zoledronate—Ibandronate—Alendronate—osteoporosis	0.00784	0.0439	CrCrCtD
Zoledronate—Ibandronate—Pamidronate—osteoporosis	0.00784	0.0439	CrCrCtD
Zoledronate—Etidronic acid—Risedronate—osteoporosis	0.00721	0.0404	CrCrCtD
Zoledronate—Risedronate—Etidronic acid—osteoporosis	0.00721	0.0404	CrCrCtD
Zoledronate—Risedronate—Pamidronate—osteoporosis	0.00678	0.0379	CrCrCtD
Zoledronate—Etidronic acid—Pamidronate—osteoporosis	0.00678	0.0379	CrCrCtD
Zoledronate—Etidronic acid—Alendronate—osteoporosis	0.00678	0.0379	CrCrCtD
Zoledronate—Risedronate—Alendronate—osteoporosis	0.00678	0.0379	CrCrCtD
Zoledronate—Pamidronate—Etidronic acid—osteoporosis	0.00637	0.0357	CrCrCtD
Zoledronate—Alendronate—Etidronic acid—osteoporosis	0.00637	0.0357	CrCrCtD
Zoledronate—Alendronate—Risedronate—osteoporosis	0.00637	0.0357	CrCrCtD
Zoledronate—Pamidronate—Risedronate—osteoporosis	0.00637	0.0357	CrCrCtD
Zoledronate—Pamidronate—Alendronate—osteoporosis	0.00599	0.0335	CrCrCtD
Zoledronate—Alendronate—Pamidronate—osteoporosis	0.00599	0.0335	CrCrCtD
Zoledronate—ABCC1—Conjugated Estrogens—osteoporosis	0.00248	0.0146	CbGbCtD
Zoledronate—GGPS1—Cholesterol biosynthesis—FDPS—osteoporosis	0.00225	0.193	CbGpPWpGaD
Zoledronate—FDPS—jaw skeleton—osteoporosis	0.00201	0.35	CbGeAlD
Zoledronate—FDPS—periosteum—osteoporosis	0.00152	0.264	CbGeAlD
Zoledronate—GGPS1—Activation of gene expression by SREBF (SREBP)—FDPS—osteoporosis	0.00139	0.12	CbGpPWpGaD
Zoledronate—CA14—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00131	0.113	CbGpPWpGaD
Zoledronate—GGPS1—Regulation of cholesterol biosynthesis by SREBP (SREBF)—FDPS—osteoporosis	0.00111	0.0956	CbGpPWpGaD
Zoledronate—CA12—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00111	0.0952	CbGpPWpGaD
Zoledronate—CA2—periosteum—osteoporosis	0.000789	0.137	CbGeAlD
Zoledronate—Ibandronate—FDPS—osteoporosis	0.000478	0.329	CrCbGaD
Zoledronate—GGPS1—uterus—osteoporosis	0.000451	0.0784	CbGeAlD
Zoledronate—Pamidronate—FDPS—osteoporosis	0.000418	0.288	CrCbGaD
Zoledronate—GGPS1—bone marrow—osteoporosis	0.000382	0.0665	CbGeAlD
Zoledronate—Risedronate—FDPS—osteoporosis	0.000337	0.232	CrCbGaD
Zoledronate—Alendronate—FDPS—osteoporosis	0.000219	0.151	CrCbGaD
Zoledronate—FDPS—uterus—osteoporosis	0.000208	0.0361	CbGeAlD
Zoledronate—FDPS—bone marrow—osteoporosis	0.000176	0.0307	CbGeAlD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000167	0.0143	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000158	0.0136	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000123	0.0106	CbGpPWpGaD
Zoledronate—ABCC1—uterus—osteoporosis	0.000121	0.021	CbGeAlD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00012	0.0103	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.57e-05	0.00822	CbGpPWpGaD
Zoledronate—CA2—bone marrow—osteoporosis	9.15e-05	0.0159	CbGeAlD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.14e-05	0.00699	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PKM—osteoporosis	7.42e-05	0.00637	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—FDPS—osteoporosis	7.42e-05	0.00637	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PGLS—osteoporosis	7.04e-05	0.00604	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GPD2—osteoporosis	7.04e-05	0.00604	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.74e-05	0.00579	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PNP—osteoporosis	6.43e-05	0.00553	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ATIC—osteoporosis	6.43e-05	0.00553	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	6.37e-05	0.00547	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CA2—osteoporosis	5.47e-05	0.0047	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—OXCT1—osteoporosis	5.47e-05	0.0047	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—MGLL—osteoporosis	5.33e-05	0.00458	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.24e-05	0.0045	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.11e-05	0.00439	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.03e-05	0.00432	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—IDH2—osteoporosis	4.53e-05	0.00389	CbGpPWpGaD
Zoledronate—ABCC1—Arachidonic acid metabolism—GPX1—osteoporosis	4.36e-05	0.00375	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP27A1—osteoporosis	4.26e-05	0.00366	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ACP5—osteoporosis	4.15e-05	0.00356	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.09e-05	0.00352	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.09e-05	0.00351	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—TPI1—osteoporosis	3.85e-05	0.00331	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PKM—osteoporosis	3.62e-05	0.00311	CbGpPWpGaD
Zoledronate—CA14—Metabolism—FDPS—osteoporosis	3.62e-05	0.00311	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—P4HB—osteoporosis	3.62e-05	0.00311	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GAPDH—osteoporosis	3.56e-05	0.00306	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.47e-05	0.00298	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—RAP1A—osteoporosis	3.46e-05	0.00298	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PGLS—osteoporosis	3.44e-05	0.00295	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPD2—osteoporosis	3.44e-05	0.00295	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PKM—osteoporosis	3.17e-05	0.00272	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ATIC—osteoporosis	3.14e-05	0.0027	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PNP—osteoporosis	3.14e-05	0.0027	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PKM—osteoporosis	3.05e-05	0.00262	CbGpPWpGaD
Zoledronate—CA12—Metabolism—FDPS—osteoporosis	3.05e-05	0.00262	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.02e-05	0.00259	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PGLS—osteoporosis	3e-05	0.00258	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPD2—osteoporosis	3e-05	0.00258	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPD2—osteoporosis	2.9e-05	0.00249	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PGLS—osteoporosis	2.9e-05	0.00249	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ENO1—osteoporosis	2.8e-05	0.00241	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PSMA2—osteoporosis	2.76e-05	0.00237	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PSMA5—osteoporosis	2.76e-05	0.00237	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PNP—osteoporosis	2.75e-05	0.00236	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ATIC—osteoporosis	2.75e-05	0.00236	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CA2—osteoporosis	2.67e-05	0.00229	CbGpPWpGaD
Zoledronate—CA14—Metabolism—OXCT1—osteoporosis	2.67e-05	0.00229	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ATIC—osteoporosis	2.65e-05	0.00227	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PNP—osteoporosis	2.65e-05	0.00227	CbGpPWpGaD
Zoledronate—CA14—Metabolism—MGLL—osteoporosis	2.6e-05	0.00224	CbGpPWpGaD
Zoledronate—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	2.59e-05	0.00222	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.54e-05	0.00218	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	2.41e-05	0.00207	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—OXCT1—osteoporosis	2.34e-05	0.00201	CbGpPWpGaD
Zoledronate—CA2—Metabolism—FDPS—osteoporosis	2.34e-05	0.00201	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PKM—osteoporosis	2.34e-05	0.00201	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CA2—osteoporosis	2.34e-05	0.00201	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—MGLL—osteoporosis	2.28e-05	0.00195	CbGpPWpGaD
Zoledronate—CA12—Metabolism—OXCT1—osteoporosis	2.25e-05	0.00193	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CA2—osteoporosis	2.25e-05	0.00193	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—CYP19A1—osteoporosis	2.24e-05	0.00192	CbGpPWpGaD
Zoledronate—CA14—Metabolism—IDH2—osteoporosis	2.21e-05	0.0019	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PGLS—osteoporosis	2.21e-05	0.0019	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPD2—osteoporosis	2.21e-05	0.0019	CbGpPWpGaD
Zoledronate—CA12—Metabolism—MGLL—osteoporosis	2.19e-05	0.00188	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.15e-05	0.00184	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP27A1—osteoporosis	2.08e-05	0.00179	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ACP5—osteoporosis	2.02e-05	0.00174	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ATIC—osteoporosis	2.02e-05	0.00174	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PNP—osteoporosis	2.02e-05	0.00174	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—IDH2—osteoporosis	1.94e-05	0.00166	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TPI1—osteoporosis	1.88e-05	0.00162	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.87e-05	0.00161	CbGpPWpGaD
Zoledronate—CA12—Metabolism—IDH2—osteoporosis	1.87e-05	0.0016	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—ADCY5—osteoporosis	1.83e-05	0.00157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.82e-05	0.00157	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—GPX1—osteoporosis	1.82e-05	0.00157	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP27A1—osteoporosis	1.82e-05	0.00156	CbGpPWpGaD
Zoledronate—CA14—Metabolism—P4HB—osteoporosis	1.77e-05	0.00152	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ACP5—osteoporosis	1.77e-05	0.00152	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP27A1—osteoporosis	1.75e-05	0.00151	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.75e-05	0.0015	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GAPDH—osteoporosis	1.74e-05	0.00149	CbGpPWpGaD
Zoledronate—CA2—Metabolism—OXCT1—osteoporosis	1.72e-05	0.00148	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ACP5—osteoporosis	1.71e-05	0.00147	CbGpPWpGaD
Zoledronate—CA14—Metabolism—RAP1A—osteoporosis	1.69e-05	0.00145	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—MTHFR—osteoporosis	1.68e-05	0.00144	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MGLL—osteoporosis	1.68e-05	0.00144	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—TPI1—osteoporosis	1.65e-05	0.00141	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TPI1—osteoporosis	1.59e-05	0.00136	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.59e-05	0.00136	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—P4HB—osteoporosis	1.55e-05	0.00133	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GAPDH—osteoporosis	1.52e-05	0.0013	CbGpPWpGaD
Zoledronate—CA12—Metabolism—P4HB—osteoporosis	1.49e-05	0.00128	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—RAP1A—osteoporosis	1.48e-05	0.00127	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GAPDH—osteoporosis	1.46e-05	0.00126	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.46e-05	0.00125	CbGpPWpGaD
Zoledronate—CA2—Metabolism—IDH2—osteoporosis	1.43e-05	0.00123	CbGpPWpGaD
Zoledronate—CA12—Metabolism—RAP1A—osteoporosis	1.43e-05	0.00122	CbGpPWpGaD
Zoledronate—Confusional state—Pamidronate—osteoporosis	1.39e-05	0.000331	CcSEcCtD
Zoledronate—Oedema—Pamidronate—osteoporosis	1.38e-05	0.000329	CcSEcCtD
Zoledronate—Anaphylactic shock—Pamidronate—osteoporosis	1.38e-05	0.000329	CcSEcCtD
Zoledronate—Infection—Pamidronate—osteoporosis	1.37e-05	0.000326	CcSEcCtD
Zoledronate—Urticaria—Calcitriol—osteoporosis	1.37e-05	0.000326	CcSEcCtD
Zoledronate—CA14—Metabolism—ENO1—osteoporosis	1.37e-05	0.00117	CbGpPWpGaD
Zoledronate—Abdominal pain—Calcitriol—osteoporosis	1.36e-05	0.000325	CcSEcCtD
Zoledronate—Body temperature increased—Calcitriol—osteoporosis	1.36e-05	0.000325	CcSEcCtD
Zoledronate—Hypoaesthesia—Estradiol—osteoporosis	1.36e-05	0.000324	CcSEcCtD
Zoledronate—Angioedema—Conjugated Estrogens—osteoporosis	1.36e-05	0.000324	CcSEcCtD
Zoledronate—Shock—Pamidronate—osteoporosis	1.36e-05	0.000323	CcSEcCtD
Zoledronate—Hypersensitivity—Estropipate—osteoporosis	1.35e-05	0.000322	CcSEcCtD
Zoledronate—Nervous system disorder—Pamidronate—osteoporosis	1.35e-05	0.000322	CcSEcCtD
Zoledronate—Thrombocytopenia—Pamidronate—osteoporosis	1.35e-05	0.000322	CcSEcCtD
Zoledronate—Urinary tract disorder—Estradiol—osteoporosis	1.35e-05	0.000322	CcSEcCtD
Zoledronate—ABCC1—Disease—PKM—osteoporosis	1.35e-05	0.00116	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SOST—osteoporosis	1.35e-05	0.00116	CbGpPWpGaD
Zoledronate—Vomiting—Etidronic acid—osteoporosis	1.35e-05	0.000321	CcSEcCtD
Zoledronate—CA14—Metabolism—PSMA2—osteoporosis	1.35e-05	0.00116	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PSMA5—osteoporosis	1.35e-05	0.00116	CbGpPWpGaD
Zoledronate—Oedema peripheral—Estradiol—osteoporosis	1.35e-05	0.000321	CcSEcCtD
Zoledronate—Tachycardia—Pamidronate—osteoporosis	1.35e-05	0.000321	CcSEcCtD
Zoledronate—GGPS1—Metabolism—POMC—osteoporosis	1.35e-05	0.00116	CbGpPWpGaD
Zoledronate—Connective tissue disorder—Estradiol—osteoporosis	1.34e-05	0.00032	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP27A1—osteoporosis	1.34e-05	0.00115	CbGpPWpGaD
Zoledronate—Urethral disorder—Estradiol—osteoporosis	1.34e-05	0.000319	CcSEcCtD
Zoledronate—Rash—Etidronic acid—osteoporosis	1.34e-05	0.000319	CcSEcCtD
Zoledronate—Dermatitis—Etidronic acid—osteoporosis	1.34e-05	0.000319	CcSEcCtD
Zoledronate—Vertigo—Conjugated Estrogens—osteoporosis	1.34e-05	0.000318	CcSEcCtD
Zoledronate—Hyperhidrosis—Pamidronate—osteoporosis	1.33e-05	0.000318	CcSEcCtD
Zoledronate—Syncope—Conjugated Estrogens—osteoporosis	1.33e-05	0.000318	CcSEcCtD
Zoledronate—Hypersensitivity—Alendronate—osteoporosis	1.33e-05	0.000317	CcSEcCtD
Zoledronate—Headache—Etidronic acid—osteoporosis	1.33e-05	0.000317	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Risedronate—osteoporosis	1.32e-05	0.000315	CcSEcCtD
Zoledronate—Asthenia—Estropipate—osteoporosis	1.32e-05	0.000314	CcSEcCtD
Zoledronate—Anorexia—Pamidronate—osteoporosis	1.32e-05	0.000313	CcSEcCtD
Zoledronate—Palpitations—Conjugated Estrogens—osteoporosis	1.31e-05	0.000313	CcSEcCtD
Zoledronate—Insomnia—Risedronate—osteoporosis	1.31e-05	0.000313	CcSEcCtD
Zoledronate—Loss of consciousness—Conjugated Estrogens—osteoporosis	1.31e-05	0.000311	CcSEcCtD
Zoledronate—CA2—Metabolism—ACP5—osteoporosis	1.3e-05	0.00112	CbGpPWpGaD
Zoledronate—Paraesthesia—Risedronate—osteoporosis	1.3e-05	0.00031	CcSEcCtD
Zoledronate—Pruritus—Estropipate—osteoporosis	1.3e-05	0.000309	CcSEcCtD
Zoledronate—Asthenia—Alendronate—osteoporosis	1.3e-05	0.000309	CcSEcCtD
Zoledronate—Hypersensitivity—Ibandronate—osteoporosis	1.3e-05	0.000309	CcSEcCtD
Zoledronate—Cough—Conjugated Estrogens—osteoporosis	1.3e-05	0.000309	CcSEcCtD
Zoledronate—Dyspnoea—Risedronate—osteoporosis	1.29e-05	0.000308	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.29e-05	0.00111	CbGpPWpGaD
Zoledronate—Hypotension—Pamidronate—osteoporosis	1.29e-05	0.000307	CcSEcCtD
Zoledronate—Convulsion—Conjugated Estrogens—osteoporosis	1.29e-05	0.000307	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	1.29e-05	0.000306	CcSEcCtD
Zoledronate—Fatigue—Ethinyl Estradiol—osteoporosis	1.28e-05	0.000306	CcSEcCtD
Zoledronate—Pruritus—Alendronate—osteoporosis	1.28e-05	0.000305	CcSEcCtD
Zoledronate—ABCC1—Disease—ANTXR2—osteoporosis	1.28e-05	0.0011	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PGLS—osteoporosis	1.28e-05	0.0011	CbGpPWpGaD
Zoledronate—Dyspepsia—Risedronate—osteoporosis	1.28e-05	0.000304	CcSEcCtD
Zoledronate—Eye disorder—Estradiol—osteoporosis	1.28e-05	0.000304	CcSEcCtD
Zoledronate—Constipation—Ethinyl Estradiol—osteoporosis	1.27e-05	0.000303	CcSEcCtD
Zoledronate—Hypersensitivity—Calcitriol—osteoporosis	1.27e-05	0.000303	CcSEcCtD
Zoledronate—Cardiac disorder—Estradiol—osteoporosis	1.27e-05	0.000302	CcSEcCtD
Zoledronate—Flushing—Estradiol—osteoporosis	1.27e-05	0.000302	CcSEcCtD
Zoledronate—Chest pain—Conjugated Estrogens—osteoporosis	1.27e-05	0.000302	CcSEcCtD
Zoledronate—Arthralgia—Conjugated Estrogens—osteoporosis	1.27e-05	0.000302	CcSEcCtD
Zoledronate—Myalgia—Conjugated Estrogens—osteoporosis	1.27e-05	0.000302	CcSEcCtD
Zoledronate—Asthenia—Ibandronate—osteoporosis	1.26e-05	0.000301	CcSEcCtD
Zoledronate—Anxiety—Conjugated Estrogens—osteoporosis	1.26e-05	0.0003	CcSEcCtD
Zoledronate—Nausea—Etidronic acid—osteoporosis	1.26e-05	0.0003	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	1.26e-05	0.000299	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Pamidronate—osteoporosis	1.26e-05	0.000299	CcSEcCtD
Zoledronate—Diarrhoea—Estropipate—osteoporosis	1.26e-05	0.000299	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Risedronate—osteoporosis	1.25e-05	0.000298	CcSEcCtD
Zoledronate—Fatigue—Risedronate—osteoporosis	1.25e-05	0.000298	CcSEcCtD
Zoledronate—Insomnia—Pamidronate—osteoporosis	1.25e-05	0.000297	CcSEcCtD
Zoledronate—Pruritus—Ibandronate—osteoporosis	1.25e-05	0.000297	CcSEcCtD
Zoledronate—Pain—Risedronate—osteoporosis	1.24e-05	0.000296	CcSEcCtD
Zoledronate—Constipation—Risedronate—osteoporosis	1.24e-05	0.000296	CcSEcCtD
Zoledronate—Angiopathy—Estradiol—osteoporosis	1.24e-05	0.000295	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.24e-05	0.00106	CbGpPWpGaD
Zoledronate—Paraesthesia—Pamidronate—osteoporosis	1.24e-05	0.000295	CcSEcCtD
Zoledronate—Diarrhoea—Alendronate—osteoporosis	1.24e-05	0.000295	CcSEcCtD
Zoledronate—Asthenia—Calcitriol—osteoporosis	1.24e-05	0.000295	CcSEcCtD
Zoledronate—Immune system disorder—Estradiol—osteoporosis	1.23e-05	0.000294	CcSEcCtD
Zoledronate—Mediastinal disorder—Estradiol—osteoporosis	1.23e-05	0.000293	CcSEcCtD
Zoledronate—Dyspnoea—Pamidronate—osteoporosis	1.23e-05	0.000293	CcSEcCtD
Zoledronate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	1.23e-05	0.000292	CcSEcCtD
Zoledronate—Chills—Estradiol—osteoporosis	1.23e-05	0.000292	CcSEcCtD
Zoledronate—Somnolence—Pamidronate—osteoporosis	1.23e-05	0.000292	CcSEcCtD
Zoledronate—Pruritus—Calcitriol—osteoporosis	1.22e-05	0.000291	CcSEcCtD
Zoledronate—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	1.22e-05	0.00029	CcSEcCtD
Zoledronate—Diarrhoea—Raloxifene—osteoporosis	1.22e-05	0.00029	CcSEcCtD
Zoledronate—Dyspepsia—Pamidronate—osteoporosis	1.21e-05	0.000289	CcSEcCtD
Zoledronate—Dizziness—Estropipate—osteoporosis	1.21e-05	0.000289	CcSEcCtD
Zoledronate—Oedema—Conjugated Estrogens—osteoporosis	1.21e-05	0.000289	CcSEcCtD
Zoledronate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	1.21e-05	0.000289	CcSEcCtD
Zoledronate—CA2—Metabolism—TPI1—osteoporosis	1.21e-05	0.00104	CbGpPWpGaD
Zoledronate—Alopecia—Estradiol—osteoporosis	1.21e-05	0.000288	CcSEcCtD
Zoledronate—Infection—Conjugated Estrogens—osteoporosis	1.21e-05	0.000287	CcSEcCtD
Zoledronate—Diarrhoea—Ibandronate—osteoporosis	1.21e-05	0.000287	CcSEcCtD
Zoledronate—Decreased appetite—Pamidronate—osteoporosis	1.2e-05	0.000286	CcSEcCtD
Zoledronate—Mental disorder—Estradiol—osteoporosis	1.2e-05	0.000285	CcSEcCtD
Zoledronate—Dizziness—Alendronate—osteoporosis	1.2e-05	0.000285	CcSEcCtD
Zoledronate—FDPS—Metabolism—ENO1—osteoporosis	1.2e-05	0.00103	CbGpPWpGaD
Zoledronate—Shock—Conjugated Estrogens—osteoporosis	1.19e-05	0.000284	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Pamidronate—osteoporosis	1.19e-05	0.000284	CcSEcCtD
Zoledronate—Nervous system disorder—Conjugated Estrogens—osteoporosis	1.19e-05	0.000283	CcSEcCtD
Zoledronate—Malnutrition—Estradiol—osteoporosis	1.19e-05	0.000283	CcSEcCtD
Zoledronate—Erythema—Estradiol—osteoporosis	1.19e-05	0.000283	CcSEcCtD
Zoledronate—Fatigue—Pamidronate—osteoporosis	1.19e-05	0.000283	CcSEcCtD
Zoledronate—Gastrointestinal pain—Risedronate—osteoporosis	1.19e-05	0.000283	CcSEcCtD
Zoledronate—Tachycardia—Conjugated Estrogens—osteoporosis	1.18e-05	0.000282	CcSEcCtD
Zoledronate—Urticaria—Ethinyl Estradiol—osteoporosis	1.18e-05	0.000282	CcSEcCtD
Zoledronate—Constipation—Pamidronate—osteoporosis	1.18e-05	0.000281	CcSEcCtD
Zoledronate—Pain—Pamidronate—osteoporosis	1.18e-05	0.000281	CcSEcCtD
Zoledronate—Diarrhoea—Calcitriol—osteoporosis	1.18e-05	0.000281	CcSEcCtD
Zoledronate—Skin disorder—Conjugated Estrogens—osteoporosis	1.18e-05	0.000281	CcSEcCtD
Zoledronate—FDPS—Metabolism—PSMA2—osteoporosis	1.18e-05	0.00101	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PSMA5—osteoporosis	1.18e-05	0.00101	CbGpPWpGaD
Zoledronate—Body temperature increased—Ethinyl Estradiol—osteoporosis	1.18e-05	0.00028	CcSEcCtD
Zoledronate—Abdominal pain—Ethinyl Estradiol—osteoporosis	1.18e-05	0.00028	CcSEcCtD
Zoledronate—Dizziness—Raloxifene—osteoporosis	1.18e-05	0.00028	CcSEcCtD
Zoledronate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	1.17e-05	0.000279	CcSEcCtD
Zoledronate—Vomiting—Estropipate—osteoporosis	1.17e-05	0.000278	CcSEcCtD
Zoledronate—Dysgeusia—Estradiol—osteoporosis	1.17e-05	0.000278	CcSEcCtD
Zoledronate—Dizziness—Ibandronate—osteoporosis	1.16e-05	0.000277	CcSEcCtD
Zoledronate—Rash—Estropipate—osteoporosis	1.16e-05	0.000276	CcSEcCtD
Zoledronate—Dermatitis—Estropipate—osteoporosis	1.16e-05	0.000276	CcSEcCtD
Zoledronate—Anorexia—Conjugated Estrogens—osteoporosis	1.16e-05	0.000276	CcSEcCtD
Zoledronate—Urticaria—Risedronate—osteoporosis	1.15e-05	0.000275	CcSEcCtD
Zoledronate—CA12—Metabolism—ENO1—osteoporosis	1.15e-05	0.00099	CbGpPWpGaD
Zoledronate—Back pain—Estradiol—osteoporosis	1.15e-05	0.000274	CcSEcCtD
Zoledronate—Headache—Estropipate—osteoporosis	1.15e-05	0.000274	CcSEcCtD
Zoledronate—Vomiting—Alendronate—osteoporosis	1.15e-05	0.000274	CcSEcCtD
Zoledronate—Abdominal pain—Risedronate—osteoporosis	1.15e-05	0.000273	CcSEcCtD
Zoledronate—Body temperature increased—Risedronate—osteoporosis	1.15e-05	0.000273	CcSEcCtD
Zoledronate—Muscle spasms—Estradiol—osteoporosis	1.14e-05	0.000273	CcSEcCtD
Zoledronate—Rash—Alendronate—osteoporosis	1.14e-05	0.000272	CcSEcCtD
Zoledronate—CA2—Metabolism—P4HB—osteoporosis	1.14e-05	0.000979	CbGpPWpGaD
Zoledronate—Dermatitis—Alendronate—osteoporosis	1.14e-05	0.000271	CcSEcCtD
Zoledronate—Feeling abnormal—Pamidronate—osteoporosis	1.14e-05	0.000271	CcSEcCtD
Zoledronate—CA12—Metabolism—PSMA2—osteoporosis	1.14e-05	0.000976	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PSMA5—osteoporosis	1.14e-05	0.000976	CbGpPWpGaD
Zoledronate—Hypotension—Conjugated Estrogens—osteoporosis	1.13e-05	0.00027	CcSEcCtD
Zoledronate—Headache—Alendronate—osteoporosis	1.13e-05	0.00027	CcSEcCtD
Zoledronate—Vomiting—Raloxifene—osteoporosis	1.13e-05	0.000269	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PKM—osteoporosis	1.13e-05	0.000971	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FDPS—osteoporosis	1.13e-05	0.000971	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Pamidronate—osteoporosis	1.13e-05	0.000269	CcSEcCtD
Zoledronate—Rash—Raloxifene—osteoporosis	1.12e-05	0.000267	CcSEcCtD
Zoledronate—Dermatitis—Raloxifene—osteoporosis	1.12e-05	0.000267	CcSEcCtD
Zoledronate—Vomiting—Ibandronate—osteoporosis	1.12e-05	0.000267	CcSEcCtD
Zoledronate—CA2—Metabolism—GAPDH—osteoporosis	1.12e-05	0.000961	CbGpPWpGaD
Zoledronate—Tremor—Estradiol—osteoporosis	1.12e-05	0.000266	CcSEcCtD
Zoledronate—Headache—Raloxifene—osteoporosis	1.11e-05	0.000265	CcSEcCtD
Zoledronate—Rash—Ibandronate—osteoporosis	1.11e-05	0.000264	CcSEcCtD
Zoledronate—Dermatitis—Ibandronate—osteoporosis	1.11e-05	0.000264	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	1.11e-05	0.000263	CcSEcCtD
Zoledronate—Ill-defined disorder—Estradiol—osteoporosis	1.1e-05	0.000263	CcSEcCtD
Zoledronate—Headache—Ibandronate—osteoporosis	1.1e-05	0.000263	CcSEcCtD
Zoledronate—Insomnia—Conjugated Estrogens—osteoporosis	1.1e-05	0.000261	CcSEcCtD
Zoledronate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	1.1e-05	0.000261	CcSEcCtD
Zoledronate—Vomiting—Calcitriol—osteoporosis	1.1e-05	0.000261	CcSEcCtD
Zoledronate—Agitation—Estradiol—osteoporosis	1.09e-05	0.00026	CcSEcCtD
Zoledronate—CA14—Metabolism—CYP19A1—osteoporosis	1.09e-05	0.000939	CbGpPWpGaD
Zoledronate—Nausea—Estropipate—osteoporosis	1.09e-05	0.00026	CcSEcCtD
Zoledronate—Abdominal pain—Pamidronate—osteoporosis	1.09e-05	0.00026	CcSEcCtD
Zoledronate—Body temperature increased—Pamidronate—osteoporosis	1.09e-05	0.00026	CcSEcCtD
Zoledronate—CA2—Metabolism—RAP1A—osteoporosis	1.09e-05	0.000936	CbGpPWpGaD
Zoledronate—Paraesthesia—Conjugated Estrogens—osteoporosis	1.09e-05	0.00026	CcSEcCtD
Zoledronate—ABCC1—Disease—GSN—osteoporosis	1.09e-05	0.000934	CbGpPWpGaD
Zoledronate—Angioedema—Estradiol—osteoporosis	1.09e-05	0.000259	CcSEcCtD
Zoledronate—Rash—Calcitriol—osteoporosis	1.09e-05	0.000259	CcSEcCtD
Zoledronate—Dermatitis—Calcitriol—osteoporosis	1.09e-05	0.000259	CcSEcCtD
Zoledronate—Dyspnoea—Conjugated Estrogens—osteoporosis	1.08e-05	0.000258	CcSEcCtD
Zoledronate—Headache—Calcitriol—osteoporosis	1.08e-05	0.000257	CcSEcCtD
Zoledronate—Somnolence—Conjugated Estrogens—osteoporosis	1.08e-05	0.000257	CcSEcCtD
Zoledronate—Nausea—Alendronate—osteoporosis	1.07e-05	0.000256	CcSEcCtD
Zoledronate—Malaise—Estradiol—osteoporosis	1.07e-05	0.000256	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PGLS—osteoporosis	1.07e-05	0.00092	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPD2—osteoporosis	1.07e-05	0.00092	CbGpPWpGaD
Zoledronate—Hypersensitivity—Risedronate—osteoporosis	1.07e-05	0.000255	CcSEcCtD
Zoledronate—Vertigo—Estradiol—osteoporosis	1.07e-05	0.000255	CcSEcCtD
Zoledronate—Dyspepsia—Conjugated Estrogens—osteoporosis	1.07e-05	0.000254	CcSEcCtD
Zoledronate—Asthenia—Ethinyl Estradiol—osteoporosis	1.07e-05	0.000254	CcSEcCtD
Zoledronate—Syncope—Estradiol—osteoporosis	1.07e-05	0.000254	CcSEcCtD
Zoledronate—Nausea—Raloxifene—osteoporosis	1.06e-05	0.000252	CcSEcCtD
Zoledronate—Decreased appetite—Conjugated Estrogens—osteoporosis	1.06e-05	0.000251	CcSEcCtD
Zoledronate—Pruritus—Ethinyl Estradiol—osteoporosis	1.05e-05	0.000251	CcSEcCtD
Zoledronate—Palpitations—Estradiol—osteoporosis	1.05e-05	0.00025	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	1.05e-05	0.00025	CcSEcCtD
Zoledronate—Fatigue—Conjugated Estrogens—osteoporosis	1.05e-05	0.000249	CcSEcCtD
Zoledronate—Nausea—Ibandronate—osteoporosis	1.05e-05	0.000249	CcSEcCtD
Zoledronate—Loss of consciousness—Estradiol—osteoporosis	1.05e-05	0.000249	CcSEcCtD
Zoledronate—Asthenia—Risedronate—osteoporosis	1.04e-05	0.000248	CcSEcCtD
Zoledronate—Cough—Estradiol—osteoporosis	1.04e-05	0.000247	CcSEcCtD
Zoledronate—Pain—Conjugated Estrogens—osteoporosis	1.04e-05	0.000247	CcSEcCtD
Zoledronate—Constipation—Conjugated Estrogens—osteoporosis	1.04e-05	0.000247	CcSEcCtD
Zoledronate—Hypertension—Estradiol—osteoporosis	1.03e-05	0.000245	CcSEcCtD
Zoledronate—Pruritus—Risedronate—osteoporosis	1.03e-05	0.000245	CcSEcCtD
Zoledronate—Nausea—Calcitriol—osteoporosis	1.02e-05	0.000244	CcSEcCtD
Zoledronate—Diarrhoea—Ethinyl Estradiol—osteoporosis	1.02e-05	0.000243	CcSEcCtD
Zoledronate—Hypersensitivity—Pamidronate—osteoporosis	1.02e-05	0.000242	CcSEcCtD
Zoledronate—Arthralgia—Estradiol—osteoporosis	1.01e-05	0.000241	CcSEcCtD
Zoledronate—Chest pain—Estradiol—osteoporosis	1.01e-05	0.000241	CcSEcCtD
Zoledronate—Myalgia—Estradiol—osteoporosis	1.01e-05	0.000241	CcSEcCtD
Zoledronate—Anxiety—Estradiol—osteoporosis	1.01e-05	0.00024	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	1.01e-05	0.00024	CcSEcCtD
Zoledronate—Discomfort—Estradiol—osteoporosis	1e-05	0.000238	CcSEcCtD
Zoledronate—Diarrhoea—Risedronate—osteoporosis	9.93e-06	0.000237	CcSEcCtD
Zoledronate—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	9.92e-06	0.000236	CcSEcCtD
Zoledronate—Dry mouth—Estradiol—osteoporosis	9.91e-06	0.000236	CcSEcCtD
Zoledronate—Asthenia—Pamidronate—osteoporosis	9.9e-06	0.000236	CcSEcCtD
Zoledronate—Dizziness—Ethinyl Estradiol—osteoporosis	9.85e-06	0.000234	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PNP—osteoporosis	9.8e-06	0.000842	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ATIC—osteoporosis	9.8e-06	0.000842	CbGpPWpGaD
Zoledronate—Confusional state—Estradiol—osteoporosis	9.79e-06	0.000233	CcSEcCtD
Zoledronate—Pruritus—Pamidronate—osteoporosis	9.76e-06	0.000232	CcSEcCtD
Zoledronate—Anaphylactic shock—Estradiol—osteoporosis	9.71e-06	0.000231	CcSEcCtD
Zoledronate—Oedema—Estradiol—osteoporosis	9.71e-06	0.000231	CcSEcCtD
Zoledronate—Infection—Estradiol—osteoporosis	9.65e-06	0.00023	CcSEcCtD
Zoledronate—Urticaria—Conjugated Estrogens—osteoporosis	9.64e-06	0.00023	CcSEcCtD
Zoledronate—Dizziness—Risedronate—osteoporosis	9.6e-06	0.000229	CcSEcCtD
Zoledronate—Body temperature increased—Conjugated Estrogens—osteoporosis	9.59e-06	0.000228	CcSEcCtD
Zoledronate—Abdominal pain—Conjugated Estrogens—osteoporosis	9.59e-06	0.000228	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP19A1—osteoporosis	9.56e-06	0.000821	CbGpPWpGaD
Zoledronate—Shock—Estradiol—osteoporosis	9.56e-06	0.000228	CcSEcCtD
Zoledronate—Nervous system disorder—Estradiol—osteoporosis	9.53e-06	0.000227	CcSEcCtD
Zoledronate—Tachycardia—Estradiol—osteoporosis	9.48e-06	0.000226	CcSEcCtD
Zoledronate—ABCC1—Disease—LRP5—osteoporosis	9.47e-06	0.000813	CbGpPWpGaD
Zoledronate—Vomiting—Ethinyl Estradiol—osteoporosis	9.47e-06	0.000225	CcSEcCtD
Zoledronate—Diarrhoea—Pamidronate—osteoporosis	9.44e-06	0.000225	CcSEcCtD
Zoledronate—Skin disorder—Estradiol—osteoporosis	9.44e-06	0.000225	CcSEcCtD
Zoledronate—Hyperhidrosis—Estradiol—osteoporosis	9.39e-06	0.000224	CcSEcCtD
Zoledronate—Rash—Ethinyl Estradiol—osteoporosis	9.39e-06	0.000224	CcSEcCtD
Zoledronate—Dermatitis—Ethinyl Estradiol—osteoporosis	9.38e-06	0.000223	CcSEcCtD
Zoledronate—Headache—Ethinyl Estradiol—osteoporosis	9.33e-06	0.000222	CcSEcCtD
Zoledronate—Vomiting—Risedronate—osteoporosis	9.23e-06	0.00022	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP19A1—osteoporosis	9.22e-06	0.000791	CbGpPWpGaD
Zoledronate—Rash—Risedronate—osteoporosis	9.15e-06	0.000218	CcSEcCtD
Zoledronate—Dermatitis—Risedronate—osteoporosis	9.14e-06	0.000218	CcSEcCtD
Zoledronate—Dizziness—Pamidronate—osteoporosis	9.13e-06	0.000217	CcSEcCtD
Zoledronate—Headache—Risedronate—osteoporosis	9.09e-06	0.000217	CcSEcCtD
Zoledronate—ABCC1—Disease—LRP6—osteoporosis	9.05e-06	0.000778	CbGpPWpGaD
Zoledronate—Hypersensitivity—Conjugated Estrogens—osteoporosis	8.94e-06	0.000213	CcSEcCtD
Zoledronate—CA14—Metabolism—ADCY5—osteoporosis	8.93e-06	0.000767	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GPX1—osteoporosis	8.9e-06	0.000765	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Estradiol—osteoporosis	8.85e-06	0.000211	CcSEcCtD
Zoledronate—Nausea—Ethinyl Estradiol—osteoporosis	8.84e-06	0.000211	CcSEcCtD
Zoledronate—CA2—Metabolism—ENO1—osteoporosis	8.81e-06	0.000757	CbGpPWpGaD
Zoledronate—Insomnia—Estradiol—osteoporosis	8.79e-06	0.000209	CcSEcCtD
Zoledronate—Vomiting—Pamidronate—osteoporosis	8.77e-06	0.000209	CcSEcCtD
Zoledronate—Paraesthesia—Estradiol—osteoporosis	8.72e-06	0.000208	CcSEcCtD
Zoledronate—Asthenia—Conjugated Estrogens—osteoporosis	8.71e-06	0.000207	CcSEcCtD
Zoledronate—Rash—Pamidronate—osteoporosis	8.7e-06	0.000207	CcSEcCtD
Zoledronate—ABCC1—Disease—LTF—osteoporosis	8.7e-06	0.000747	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL24—osteoporosis	8.7e-06	0.000747	CbGpPWpGaD
Zoledronate—Dermatitis—Pamidronate—osteoporosis	8.69e-06	0.000207	CcSEcCtD
Zoledronate—CA2—Metabolism—PSMA2—osteoporosis	8.69e-06	0.000746	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PSMA5—osteoporosis	8.69e-06	0.000746	CbGpPWpGaD
Zoledronate—Dyspnoea—Estradiol—osteoporosis	8.66e-06	0.000206	CcSEcCtD
Zoledronate—Headache—Pamidronate—osteoporosis	8.64e-06	0.000206	CcSEcCtD
Zoledronate—Somnolence—Estradiol—osteoporosis	8.64e-06	0.000206	CcSEcCtD
Zoledronate—Nausea—Risedronate—osteoporosis	8.62e-06	0.000205	CcSEcCtD
Zoledronate—Pruritus—Conjugated Estrogens—osteoporosis	8.59e-06	0.000204	CcSEcCtD
Zoledronate—Dyspepsia—Estradiol—osteoporosis	8.55e-06	0.000204	CcSEcCtD
Zoledronate—Decreased appetite—Estradiol—osteoporosis	8.44e-06	0.000201	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Estradiol—osteoporosis	8.39e-06	0.0002	CcSEcCtD
Zoledronate—Fatigue—Estradiol—osteoporosis	8.37e-06	0.000199	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CA2—osteoporosis	8.33e-06	0.000716	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—OXCT1—osteoporosis	8.33e-06	0.000716	CbGpPWpGaD
Zoledronate—Pain—Estradiol—osteoporosis	8.31e-06	0.000198	CcSEcCtD
Zoledronate—Constipation—Estradiol—osteoporosis	8.31e-06	0.000198	CcSEcCtD
Zoledronate—Diarrhoea—Conjugated Estrogens—osteoporosis	8.3e-06	0.000198	CcSEcCtD
Zoledronate—CA14—Metabolism—MTHFR—osteoporosis	8.22e-06	0.000706	CbGpPWpGaD
Zoledronate—Nausea—Pamidronate—osteoporosis	8.2e-06	0.000195	CcSEcCtD
Zoledronate—ABCC1—Metabolism—MGLL—osteoporosis	8.12e-06	0.000698	CbGpPWpGaD
Zoledronate—Dizziness—Conjugated Estrogens—osteoporosis	8.03e-06	0.000191	CcSEcCtD
Zoledronate—Feeling abnormal—Estradiol—osteoporosis	8e-06	0.000191	CcSEcCtD
Zoledronate—Gastrointestinal pain—Estradiol—osteoporosis	7.94e-06	0.000189	CcSEcCtD
Zoledronate—FDPS—Metabolism—ADCY5—osteoporosis	7.81e-06	0.000671	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—GPX1—osteoporosis	7.78e-06	0.000668	CbGpPWpGaD
Zoledronate—Vomiting—Conjugated Estrogens—osteoporosis	7.72e-06	0.000184	CcSEcCtD
Zoledronate—Urticaria—Estradiol—osteoporosis	7.72e-06	0.000184	CcSEcCtD
Zoledronate—Abdominal pain—Estradiol—osteoporosis	7.68e-06	0.000183	CcSEcCtD
Zoledronate—Body temperature increased—Estradiol—osteoporosis	7.68e-06	0.000183	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.66e-06	0.000658	CbGpPWpGaD
Zoledronate—Rash—Conjugated Estrogens—osteoporosis	7.65e-06	0.000182	CcSEcCtD
Zoledronate—Dermatitis—Conjugated Estrogens—osteoporosis	7.65e-06	0.000182	CcSEcCtD
Zoledronate—Headache—Conjugated Estrogens—osteoporosis	7.6e-06	0.000181	CcSEcCtD
Zoledronate—ABCC1—Disease—ACP5—osteoporosis	7.54e-06	0.000648	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ADCY5—osteoporosis	7.53e-06	0.000647	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GPX1—osteoporosis	7.5e-06	0.000644	CbGpPWpGaD
Zoledronate—Nausea—Conjugated Estrogens—osteoporosis	7.21e-06	0.000172	CcSEcCtD
Zoledronate—FDPS—Metabolism—MTHFR—osteoporosis	7.18e-06	0.000617	CbGpPWpGaD
Zoledronate—Hypersensitivity—Estradiol—osteoporosis	7.16e-06	0.00017	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP19A1—osteoporosis	7.05e-06	0.000605	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TPI1—osteoporosis	7.01e-06	0.000602	CbGpPWpGaD
Zoledronate—Asthenia—Estradiol—osteoporosis	6.97e-06	0.000166	CcSEcCtD
Zoledronate—CA12—Metabolism—MTHFR—osteoporosis	6.93e-06	0.000595	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH2—osteoporosis	6.91e-06	0.000593	CbGpPWpGaD
Zoledronate—Pruritus—Estradiol—osteoporosis	6.87e-06	0.000164	CcSEcCtD
Zoledronate—Diarrhoea—Estradiol—osteoporosis	6.65e-06	0.000158	CcSEcCtD
Zoledronate—ABCC1—Disease—P4HB—osteoporosis	6.59e-06	0.000566	CbGpPWpGaD
Zoledronate—CA14—Metabolism—POMC—osteoporosis	6.57e-06	0.000564	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP27A1—osteoporosis	6.49e-06	0.000558	CbGpPWpGaD
Zoledronate—ABCC1—Disease—GAPDH—osteoporosis	6.47e-06	0.000556	CbGpPWpGaD
Zoledronate—Dizziness—Estradiol—osteoporosis	6.42e-06	0.000153	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ACP5—osteoporosis	6.32e-06	0.000542	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.24e-06	0.000536	CbGpPWpGaD
Zoledronate—Vomiting—Estradiol—osteoporosis	6.18e-06	0.000147	CcSEcCtD
Zoledronate—ABCC1—Disease—NFATC1—osteoporosis	6.15e-06	0.000528	CbGpPWpGaD
Zoledronate—Rash—Estradiol—osteoporosis	6.12e-06	0.000146	CcSEcCtD
Zoledronate—Dermatitis—Estradiol—osteoporosis	6.12e-06	0.000146	CcSEcCtD
Zoledronate—ABCC1—Disease—DKK1—osteoporosis	6.1e-06	0.000524	CbGpPWpGaD
Zoledronate—Headache—Estradiol—osteoporosis	6.09e-06	0.000145	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.95e-06	0.000511	CbGpPWpGaD
Zoledronate—ABCC1—Disease—WNT1—osteoporosis	5.88e-06	0.000505	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TPI1—osteoporosis	5.87e-06	0.000504	CbGpPWpGaD
Zoledronate—Nausea—Estradiol—osteoporosis	5.77e-06	0.000137	CcSEcCtD
Zoledronate—CA2—Metabolism—ADCY5—osteoporosis	5.76e-06	0.000494	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—POMC—osteoporosis	5.74e-06	0.000493	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—osteoporosis	5.74e-06	0.000493	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGA—osteoporosis	5.72e-06	0.000491	CbGpPWpGaD
Zoledronate—CA12—Metabolism—POMC—osteoporosis	5.54e-06	0.000476	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—P4HB—osteoporosis	5.52e-06	0.000474	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GAPDH—osteoporosis	5.42e-06	0.000465	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—osteoporosis	5.3e-06	0.000455	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RAP1A—osteoporosis	5.28e-06	0.000453	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ENO1—osteoporosis	5.09e-06	0.000438	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PSMA2—osteoporosis	5.02e-06	0.000431	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PSMA5—osteoporosis	5.02e-06	0.000431	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALCA—osteoporosis	4.68e-06	0.000402	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.6e-06	0.000395	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ENO1—osteoporosis	4.27e-06	0.000366	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KL—osteoporosis	4.25e-06	0.000365	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—osteoporosis	4.23e-06	0.000364	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMA5—osteoporosis	4.2e-06	0.000361	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PSMA2—osteoporosis	4.2e-06	0.000361	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP19A1—osteoporosis	3.41e-06	0.000293	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADCY5—osteoporosis	3.33e-06	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—osteoporosis	3.06e-06	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS2—osteoporosis	2.91e-06	0.00025	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADCY5—osteoporosis	2.79e-06	0.000239	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—osteoporosis	2.78e-06	0.000239	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—osteoporosis	2.56e-06	0.00022	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IRS1—osteoporosis	2.54e-06	0.000218	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6R—osteoporosis	2.39e-06	0.000205	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—osteoporosis	2.05e-06	0.000176	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—osteoporosis	1.42e-06	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—osteoporosis	1.41e-06	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—osteoporosis	1.06e-06	9.13e-05	CbGpPWpGaD
